It is commonly accepted that accurate monitoring of neurodegenerative diseases is crucial for effective disease management and delivery of medication and treatment. This research develops automatic clinical monitoring techniques for Parkinson's disease (PD), following treatment, using the novel application of evolutionary algorithms (EAs). Specifically, the research question addressed was: Can accurate monitoring of PD be achieved using EAs on rs-fMRI data for patients prescribed Modafinil (typically prescribed for PD patients to relieve physical fatigue)?
Introduction
By 2050, 22% of the global population will be over 60 years of age, which is double the current proportion (estimated at 11%, 2000) . During the early 20th Century, life expectancy in developed nations averaged 50 years of age, whereas in 2014, life expectancy was estimated at an average 80 years of age. This explosion in life expectancy is attributed largely to advances regarding sanitation, medicine, and living conditions [3] - [5] . An ageing population is not without challenges as the biological and cognitive decline associated with ageing is the leading cause of non-communicable diseases, such as cancer, stroke, type-two diabetes, Parkinson's disease (PD) [6] , [7] and Alzheimer's disease, amongst others. As such, the World Health Organization's "Draft Twelfth General Programme of Work" (April 13, 2013) lists "Addressing the challenge of non-communicable diseases" [8] as a salient issue. The current research develops a new method of monitoring PD, a neurodegenerative disease (a class of non-communicable diseases), using evolutionary algorithms (EAs). PD occurs in 0.1-0.2% of the population, in 1-2 % of individuals over 60 years old [9] , and it is more common in men [10] . Age is the largest risk factor for PD [7] , [11] , and increases prevalence by over 400%. Age further increases PD severity to a greater extent than disease duration [6] , [11] . PD occurs in all ethnic groups and countries, yet, it is more frequent in Caucasians relative to Asians and Africans [10] . In the United Kingdom (UK), research using data acquired from the National Health Service (NHS) General Practice Research Database1 (2009) estimated PD prevalence at 0.3% (0.3% for men and 0.2% for women), which corresponds to 126,893 PD patients2. Given a globally ageing population, UK prevalence is estimated to raise 28% by 2020.
Modafinil (Provigil) is a multipurpose drug used in the treatment of sleep disorders, such as narcolepsy [12] , [13] , and it improves cognitive function in psychiatric disorders, for instance schizophrenia [14] - [16] . Modafinil is a fatigue-reducing medication that boosts attention and memory. Approximately half of PD patients report fatigue-related symptoms [17] , for which Modafinil is a common medication that clinicians prescribe [17] - [20] . Research has linked 1 World's biggest database of anonymised longitudinal medical records, comprising approximately 3.4 million people's records 2 Approximate number of cases per country: 108,000 in England, 10,000 in Scotland, 5,900 in Wales and 3,000 in Northern Ireland.
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Modafinil to enhanced attention and memory [21] - [23] and it is well tolerated by patients and has no effect on PD movement symptoms [24] . More recently, Modafinil has been used as a "smart drug", with approximately 25% of students at Oxford, Newcastle, and Leeds having tried this drug [25] . In a 2013 interview with the Telegraph, Prof Sahakian of clinical neuropsychology (University of Cambridge) mentioned that the number of students taking Modafinil was increasing alarmingly [26] . There is much controversy regarding the use of psychostimulants or "smart drugs" to heighten cognitive abilities [27] . Research suggests that Modafinil results in less side effects and lower addition risks, relative to stimulants such as methylphenidate [28] and amphetamine [29] , with benefits similar to those provided by these drugs. Yet, Modafinil has a large impact on the dopaminergic system, indicating possibly stronger addiction risks than previously estimated [30] .
Even though Modafinil is regularly prescribed to PD patients, evidence supporting its effectiveness as a fatigue-reducing drug is mixed. For instance, Lou et al. conducted a longitudinal study testing participants multiple times over two months and revealed that Modafinil can diminish physical fatigue in PD patients, as noted by the Epworth Sleepiness Scale and by a finger-tapping task following two months of treatment [19] . Other research has revealed that Modafinil relieves fatigue, as measured by the Global Clinical Impression Scale for Fatigue, and reduces excessive daytime somnolence [20] . Nevertheless, this same research revealed no relief from fatigue as measured by the Fatigue Severity Scale. A crucial point is that, regardless of the effectiveness of Modafinil in reducing fatigue, it is commonly prescribed to PD patients.
Learning Algorithms
Regular monitoring every six months of motor and non-motor symptoms via outpatient clinic appointments is necessary to ensure patients are administered appropriate levels of medication, given their changing symptomology (and medication side effects). Unfortunately, it is common for drugs administered to treat one symptom to also aggravate another symptom. For instance, D1 dopamine agonists reduce bradykinesia but worsen hallucinations and levodopa reduces tremor but worsens dyskinesia. Therefore, clinicians need to make a trade-off between the benefits (reducing PD symptoms) and costs (side effects) when prescribing medication. Hence, Networks (RSN) and the intrinsic connectivity are explored, and these data are subjected to a classifier to examine the physiological impact of Modafinil.
rs-fMRI Data
There is a broad literature on rs-fMRI [33] - [35] , including research examining the classification of participant groups or brain states using functional connectivity. For example, Esposito et al. explored resting state functional connectivity differences in participants administered Modafinil [2] . rs-fMRI enable researchers to examine specific questions that are not suited to task-related fMRI paradigms, focusing on changes in functional connectivity [36] and facilitating the concurrent exploration of multiple cortical circuits. In addition, confounding variables (e.g., between participant variance in task performance) are reduced given that participants are at rest [37] .
Rest activation is linked to minimum ten [38] - [41] functional RSN [38] , such as the Default Mode Network (DMN) [42] , the Salience Network, the Fronto Parietal Control (FPC) network (lateralised in both hemispheres), the primary Sensory Motor Network, the Exstrastriate Visual System, and the Dorsal Attention Network [38] . DMN is typically examined when conducting rs-fMRI research and, therefore, it is explored in the current study. Abnormal patterns of activation can be investigated using functional connectivity, nevertheless, causal influences (effective connectivity, i.e., the causal impact of one neuronal system on another) cannot be determined [43] . Dynamic Causal Modeling (DCM) [43] - [46] , in contrast, is derived from a PD Monitoring neuronal model of coupled neuronal states and enables investigation of the effective connectivity underlying functional connectivity via nonlinear designs to detect a generative model of measured neural activity [47] . The current research applies EAs, specifically CGP and RCGP, for the classification of rs-fMRI in PD using DCM and timeseries analyses. for classification with limited research even applying DCM to clinical data [48] - [53] . By addressing these questions, the research develops automatic procedures for locating brain imaging preclinical biomarkers, these being are crucial for PD monitoring.
Class-Imbalanced Samples
This research involved an analysis of data acquired from OpenfMRI, in which there are unequal group sample sizes. Recruiting equal sample sizes of patients and healthy controls is a common challenge in medical research. When there are unequal groups of controls versus patients the data is described as being class-imbalanced. Imbalanced data reduces classification accuracy [54] - [56] , given that classification methods typically assume balanced class distributions [57] .
Four implications of class-imbalanced data are as follows: (1) the training set sample size is reduced since classifiers typically consider that imbalanced data has limited sample sizes; (2) learning is biased towards classes with bigger sample sizes; (3) classification rules predicting the majority class tend to be specialised, hence, with low coverage, and so general rules (predicting the minority class) are prioritised; and (4) the classifier may incorrectly label small groups of minority class data as noise and reject these. Further, classification of the minority class can be worsened by the presence of genuine noise data, given the small sample size available, as there is less accurate data available with which to train the classifier [58] .
Solutions commonly involve changing/generating data to obtain more balanced classdistributions, resulting in heightened classification accuracy [59] - [61] . This research applies ADASYN [62] to generate synthetic data leading to balanced class-distributions for the training set. Nevertheless, a limitation of generating synthetic balanced data is that it is applied only to the training sets. The classifier trained for CV is a different classifier with a different accuracy level than that used in the classification part. Therefore, classification accuracy for the validation and test sets is typically reduced. Indeed, the development of accurate classifiers that can be applied to heavily class-imbalanced data with the objective of detecting a minority class (e.g., PD patients) are required.
Research Overview and Aims
The current research adopts a novel and exploratory approach to develop novel clinical monitoring tools using data from a controlled experiment in which participants were administered the drug Modafinil, typically prescribed for PD patients to relieve physical fatigue. Specifically, this experiment explored the question: Can accurate monitoring of PD be achieved using EAs on rs-fMRI data for patients prescribed Modafinil? This research involved an analysis of rs-fMRI data taken from OpenfMRI database (accession number: ds000133;
[1]), in which healthy young adults were administered a single dose of 100 mg of Modafinil (versus not). In the current research, the activity of the RSN and the functional connectivity were examined, and this data was subjected to classification to explore the physiological impact of Modafinil.
This research applied EAs, specifically CGP and Recurrent CGP (RCGP), for the classification of rs-fMRI using DCM and timeseries analyses. Supervised classification was conducted on the timeseries and DCM analyses from the rs-fMRI data. CGP and RCGP have not hitherto been applied to the classification of brain imaging data. Moreover, this research explores a further novel question: is DCM analysis relevant for classification? Research has not examined the usefulness of DCM analyses for classification.
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A common limitation in medical research involves recruiting equal sample sizes of patients and healthy controls, often leading to class-imbalanced data (e.g., unequal groups of controls versus patients). The OpenfMRI dataset used in this experiment is heavily class-imbalanced, with many more control participants relative to participants administered Modafinil. Hence, this research explored the applicability of classification methods to class-imbalanced data, with implications for the transferability of medical research based on limited and imbalanced sample sizes.
Methods

Participants
Twenty-six male participants were tested (age range: 25-35 years 
Procedure
Participants were told to consume their normal amount of nicotine and caffeine and to refrain from consuming alcohol 12 hours prior to the study. Participants were administered Modafinil (100 mg) or placebo. The study was double blind and both the Modafinil and placebo pills looked identical. Following consumption of the drug, participants were given an fMRI scan.
Data from all participants were processed and separated into their corresponding treatment groups (Modafinil and placebo). Data from one control participant was excluded, as this data was too poor quality to be analysed. Pre-session data was also categorised as placebo/control as this research only examines the effect of Modafinil on brain functionality. The Modafinil group contains 39 participants: 13 participants tested in one session with three runs. The control group contains 111 participants: 12 participants tested in two sessions with three runs plus 13 participants tested in one session with three runs.
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rs-fMRI Acquisition
rs-fMRI BOLD data was separated in three runs (duration: 4 min each) and then high resolution T1 anatomical images were acquired. Participants were instructed to focus on the centre of a grey screen that was projected on an LCD screen, viewed via a mirror located over the 
Imaging Data Analysis
Preprocessing
The imaging data analyses were conducted with CONN (version 17.c) [64] and SPM12
(version 6906 -Wellcome Department of Imaging Neuroscience, London, UK) [65] software packages based on MATLAB. Preprocessing included 4D NIFTI import, 4D to 3D NIFTI conversion, and decrease of spatial distortion via the Field Map toolbox in SPM12 [65] .
Anatomical data was segmented and both anatomical and functional data were normalised. All the functional images were motion corrected and coregistered to participants' own highresolution anatomical image. The participants' anatomical images were normalised to the standard T1 template in the MNI space, as provided by SPM12. Subsequently, the normalisation parameters of each participant were applied to the functional images to normalise all the functional images into the MNI space. The EPI data was unwarped (using field-map images) to compensate for the magnetic field inhomogeneities, realigned to correct for motion, and slice-time corrected to the middle slice. The normalisation parameters from the T1 stream were then applied to warp the functional images into MNI space. All the functional images PD Monitoring were spatially smoothed using a Gaussian kernel with 8 mm FWHM [66] to account for interparticipant variability while maintaining a relatively high spatial resolution. Linear and quadratic detrending of the fMRI signal was applied, which involved covarying out WM and CSF signal. WM and CSF signals were predicted for each volume from the mean value of WM and CSF masks, derived by thresholding SPM's tissue probability maps at 0.5. The data was bandpass filtered (0.008-0.1 Hz).
Processing
Timeseries
Functional connectivity in DMN is well studied. Hence, this research took as regions of interest matrix, all parameters of intrinsic/effective connectivity [43] ) from each participant were subjected to classification using CGP.
Cartesian Genetic Programming
CGP [67] is a strand of GP [68] , [69] , that encodes computational structures as generic cyclic/acyclic graphs. For this research, a new cross platform open source CGP library [70] was used since it is able to evolve symbolic expressions, Boolean logic circuits, and ANN, and it can be extended to diverse research areas. The CGP library enables the control of evolutionary parameters and the application of custom evolutionary stages.
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Classification
To have equal class representation, data from each class was divided randomly into subsets of 70% (training), 15% (validation), and 15% (test). The geometry of the programs in the population (chromosomes) has fifty nodes with a function set of four mathematical operations (+, -, ×, ÷), multiple inputs (according to the datasets), and one output (class 1 for Modafinil participant group, class 0 for the control participant group). At each generation, the fittest chromosome is selected and the next generation is formed with its mutated versions (mutation rate = 0.1). Evolution stops when 15000 iterations are reached. To obtain statistical significance, the classification was done in 10 runs for each combination of inputs and the accuracy was averaged over the runs. The results (the winning chromosome, the networks, and the accuracy values) were stored for each run individually.
Classification of Timeseries
rs-fMRI is a widespread tool for exploring the functionality of the brain, using volume Classification was completed in 10 runs per combination of inputs and the mean across the runs was calculated. The same inputs were used to classify the data using ANN and SVM in MATLAB for comparison/validation. RCGP was used with 10% probability for the recurrent connections. A complete pipeline of the preprocessing and processing of the data is presented in Figure 2 . 
Classification of DCM
The classification was run in the CGP Library with 16 inputs (all the DCM values sorted by region and presented as only one vector for each participant). To facilitate comparison, the classification with data from the same participants was run using ANN and SVM, both run in MATLAB.
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Adaptive Synthetic Sampling
As previously mentioned, the Modafinil group contained 39 participants and the control group contained 111 participants, resulting in highly imbalanced data. Hence, ADASYN was used to make the data balanced. After the process, the minor group for each combination (in the training set) had a higher number of participants, which made the data balanced for crossvalidation (CV). The validation and test sets were kept the same.
k-Fold Cross-Validation
10-fold CV was used to evaluate the classification accuracy using an unbiased estimate of the generalisation accuracy [71] . Advantages of CV include generating of independent test sets with improved reliability. With 10-fold CV, typically one (of 10) subset is the test set and remaining nine subsets are training sets. These sets are then rotated so that each set is used to test the data once. One repetition of the 10-fold CV does not produce sufficient classification accuracies for comparison, therefore, 10-fold CV is repeated 10 independent times and the mean accuracy over all 10 trials is calculated.
Since the main classification methodology in this research involved dividing the data into three different subsets (training, validation, and test), the data was divided into 10 subsets and, each time, one of the 10 subsets were used as the test set, another one for validation, and the remaining eight as a training set. The data was divided using stratified random sampling enabling the sample proportion in each data subset to be the same as that in the original data (i.e., equal class distribution in the subsets as per the original data). Hence, the data was split for each class initially and then the classes were mixed to form the completed set. This was done for each combination of inputs to both CGP (for DCM values) and RCGP (for timeseries values). In this study, the data for each combination of inputs was divided into three parts of 80% (training), 10% (validation), and 10% (test).
Results
This study examined the classification of 39 participants administered Modafinil versus 111 control participants. The analysis (classification) focused on organising features to be used as PD Monitoring inputs to the classifier in CGP and also in RCGP, implemented using the CGP Library. To validate the results, the analysis/classification was additionally completed using ANN and SVM, both in MATLAB.
Classification of Timeseries
Initially, the timeseries values for each region were used as inputs to the classifier individually. Unlike for the DCM analyses, mixed ANOVAs were not conducted to evaluate the correspondence between participant group and timeseries features, given that there were 580 features per participant, which would not be interpretable.
Classification of Dynamic Causal Modeling (DCM)
Classification using the CGP Library was executed with 16 inputs (all the DCM values sorted by region and presented as one vector for each participant) and 1 output (class 1 for the Modafinil group and class 0 for the control group). The results were then averaged over 10 PD Monitoring runs and are presented in Table 2 . The classification was done using ANN and SVM. For SVM, only the training and test sets were considered for classification. Two examples of the CGP classification network trees/graphs can be seen in Figure 3 and Figure 4 reveals that only 11 of the inputs are used and the network evolved, in this case, is arguably somewhat simpler than that depicted in Figure 3 .
Future work can explore constraining the geometry of the classifier (at the cost of classification accuracy) in order to simplify the networks and enhance interpretability. 
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k-Fold Cross-Validation
To evaluate the performance of the classifier, k-fold CV was conducted on all the different combinations of inputs for both DCM and timeseries values.
Cross-Validation for RCGP for Timeseries
The inputs were divided into 10 folds with 80% of the data used for training, 10% for validation, and 10% for test. After the artificial data samples were synthesised for the minor class in the training set, CV was repeated for 10 runs and the results were averaged, as shown in Table 3 . Findings indicated that the Modafinil group were successfully classified from the control group with a maximum accuracy of 63.13% using RCGP in CV (minimum accuracy: 51.67%). 
Cross-Validation for CGP for DCM
The inputs were divided into 10 folds with 80% of the data used for training, 10% for validation, and 10% for test. After the artificial data samples were synthesised for the minor class in the training set, CV was repeated for 10 runs and the results were averaged, as shown in Table 4 . Findings revealed that the Modafinil group were successfully classified from the control group with 59.55% accuracy using CGP in CV. 
Discussion
This research develops methods for differentiating clinical groups using EAs on rs-fMRI data, based on a controlled clinical experiment. Specifically, this experiment examined the monitoring of participants administered Modafinil (versus a control group) using rs-fMRI data.
These findings build on previous research exploring the application of EAs for monitoring PD patients following treatment with Levodopa [72] .
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A distinctive element of this research involved the use of DCM analysis for classification. CGP classification method was used for timeseries analyses and DCM analyses and these findings were validated with two other widely used classification techniques (ANN and SVM). Findings were further validated using k-fold CV technique. Given that the data was highly imbalanced, ADASYN was used to balance the data before performing CV, providing a more equal class distribution within the training set (i.e., balanced numbers of Modafinil and control participants A key aspect of this research involved the application of a dynamical method of classification (RCGP). CGP has been previously used in the classification of biomedical data but not brain imaging data. This research applied CGP to rs-fMRI data, a timely approach given that fMRI is a non-invasive method that generates images with high spatial resolution and good temporal resolution and it is widely used in medical facilities [73] - [76] (e.g., for diagnosis).
fMRI data is dynamic as biomedical data from the nervous system are complex, nonlinear and nonstationary. Nevertheless, research on the classification of biomedical timeseries data typically uses static classifiers (e.g., SVM [77] and feed-forward neural networks [78] ; see also [79] , [80] ). Other research has compared dynamical to static classifiers for biomedical data, revealing better discrimination and increased diversity in dynamical classifiers [32] . The current research used two static classifiers (SVM and ANN) to validate the findings from a dynamical classifier (RCGP) for the classification of timeseries data, which revealed comparable findings between all three methods. Whilst dynamical classifiers might theoretically better represent the nature of biomedical imaging data, future research is needed to further examine this question.
This research used a novel approach, applying classification to DCM data. Findings revealed that DCM data for classification provided comparable accuracy across all three classifiers, relative to timeseries data, which is surprising as other research has revealed that classification often provides better accuracies with raw unprocessed data. Timeseries data is raw fMRI data and includes over 100 features. In contract, DCM data is processed, representing the effective connectivity (the causal effect) of one neuronal region on another and, in this case, contained only 16 features. These findings underscore the relevance of DCM data for classification, even though this data is processed and contains much less features relative to timeseries data.
Following k-fold CV, classification accuracy for timeseries values decreased to 52-63% and for DCM values accuracy was reduced to 60%. This is due to the fact that this research used heavily class-imbalanced data containing 39 Modafinil participants and 111 control
participants. Yet, standard classification methods typically assume balanced class distributions.
Imbalanced data significantly reduces classification accuracy [56] given that the classifier cannot be trained efficiently to distinguish the differences between features in the two classes.
A widely used solution involves modifying the data to obtain a sample with balanced class distributions, which often increases the overall classification accuracy compared to the original imbalanced sample [59] - [61] . Nevertheless, this solution is not perfect given that the balanced data is only used in the training set, which compromises the accuracy in the validation and test sets as the classifier that was trained for the CV is a different classifier with a different accuracy level than that used in the classification part. The current research used ADASYN to balance the training set. The fact that findings revealed accuracies of approximately up to 75% in the classification of Modafinil timeseries and DCM data speaks to the robustness of CGP as a classification method, even for highly imbalanced data as in this research.
Conclusion
To conclude, this research explored the classification of participants administered Modafinil (versus a control group) applying both novel data (DCM values) and classification technique (CGP). This demonstrates the power of the technique to monitor PD patients in response to the medication they are receiving as their medication is adjusted. These results add to previous literature examining EAs for monitoring PD patients following Levodopa treatment [72] .
Classification accuracy for DCM analyses was compared to that of timeseries analyses.
results, including employing k-fold CV. Findings revealed a maximum accuracy of 75% for CGP. Classification accuracy was equivalent for DCM analyses and timeseries analyses and, further, accuracy did not differ by method (CGP, ANN, or SVM). These findings underscore the relevance of CGP as a novel classification method for dynamic brain imaging data, for both processed data (as per DCM values) and raw data (i.e., timeseries). Hence, the methods developed are potentially relevant for drug treatment monitoring and for differentiating between clinical groups, for instance, the diagnosis of patients relative to healthy controls.
Applying these methods developed to a clinical sample of PD patients and examining the transferability of these tools is a crucial future direction.
